A detailed history of Point72 (Difc) LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 14,900 shares of GILD stock, worth $1.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,900
Previous 17,889 16.71%
Holding current value
$1.34 Million
Previous $1.23 Billion 1.78%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $1.36 Million - $1.57 Million
-21,490 Reduced 54.57%
17,889 $1.23 Billion
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $2.82 Million - $3.44 Million
39,379 New
39,379 $2.88 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.